+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Endoscopic Retrograde Cholangiopancreatography Market Research Report by Product, Procedure, End-User, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - United States Forecast 2023-2030

  • PDF Icon

    Report

  • 129 Pages
  • January 2023
  • Region: United States
  • 360iResearch™
  • ID: 5721751
The United States Endoscopic Retrograde Cholangiopancreatography Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the United States Endoscopic Retrograde Cholangiopancreatography Market.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the United States Endoscopic Retrograde Cholangiopancreatography Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the United States Endoscopic Retrograde Cholangiopancreatography Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The United States Endoscopic Retrograde Cholangiopancreatography Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the United States Endoscopic Retrograde Cholangiopancreatography Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan. This research report categorizes the United States Endoscopic Retrograde Cholangiopancreatography Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market is studied across Endoscopes, Endotherapy Devices, Energy Devices, and Visualization Systems. The Endotherapy Devices is is further studied across Balloons, Baskets, Cannulas, Catheters, Forceps, Guiding Wires, Lithotripter, Snares, Sphincterotomes, and Stents.
  • Based on Procedure, the market is studied across Biliary Dilatation, Biliary Sphincterotomy, Biliary Stenting, Pancreatic Duct Dilatation, Pancreatic Duct Stenting, and Pancreatic Sphincterotomy.
  • Based on End-User, the market is studied across Ambulatory Surgery Centres & Clinics and Hospitals.
  • Based on State, the market is studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the United States Endoscopic Retrograde Cholangiopancreatography Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The United States Endoscopic Retrograde Cholangiopancreatography Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The United States Endoscopic Retrograde Cholangiopancreatography Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The United States Endoscopic Retrograde Cholangiopancreatography Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Endoscopic Retrograde Cholangiopancreatography Market, including B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, CONMED Corporation, Cook Group Incorporated, Fujifilm Holdings Corporation, Johnson & Johnson Services, Inc., KARL STORZ SE & Co. KG, Machida Endoscope Co., Ltd, Medi-Globe GmbH, Medtronic PLC, Merit Medical Systems, Inc., Olympus Corporation, Ottomed Endoscopy, PENTAX Medical, Richard Wolf GmbH, Smith & Nephew PLC, STERIS, and Stryker Corporation.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Endoscopic Retrograde Cholangiopancreatography Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Endoscopic Retrograde Cholangiopancreatography Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Endoscopic Retrograde Cholangiopancreatography Market?
4. What is the competitive strategic window for opportunities in the United States Endoscopic Retrograde Cholangiopancreatography Market?
5. What are the technology trends and regulatory frameworks in the United States Endoscopic Retrograde Cholangiopancreatography Market?
6. What is the market share of the leading vendors in the United States Endoscopic Retrograde Cholangiopancreatography Market?
7. What modes and strategic moves are considered suitable for entering the United States Endoscopic Retrograde Cholangiopancreatography Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Potential need attributed to rising prevalence of gastrointestinal and chronic biliary disorders
5.1.1.2. Significant consumer healthcare spending with rising need for minimally invasive endoscopic surgeries
5.1.2. Restraints
5.1.2.1. Concerns associated with occurrence of complications during ERCP procedures
5.1.3. Opportunities
5.1.3.1. Ongoing rise in research and development activities with heavy investments for advancement of endoscopic procedures
5.1.4. Challenges
5.1.4.1. Limited availability of skilled professionals and trained endoscopists
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Endoscopic Retrograde Cholangiopancreatography Market, by Product
6.1. Introduction
6.2. Endoscopes
6.3. Endotherapy Devices
6.4.1. Balloons
6.4.2. Baskets
6.4.3. Cannulas
6.4.4. Catheters
6.4.5. Forceps
6.4.6. Guiding Wires
6.4.7. Lithotripter
6.4.8. Snares
6.4.9. Sphincterotomes
6.4.10. Stents
6.4. Energy Devices
6.5. Visualization Systems

7. Endoscopic Retrograde Cholangiopancreatography Market, by Procedure
7.1. Introduction
7.2. Biliary Dilatation
7.3. Biliary Sphincterotomy
7.4. Biliary Stenting
7.5. Pancreatic Duct Dilatation
7.6. Pancreatic Duct Stenting
7.7. Pancreatic Sphincterotomy

8. Endoscopic Retrograde Cholangiopancreatography Market, by End-User
8.1. Introduction
8.2. Ambulatory Surgery Centres & Clinics
8.3. Hospitals

9. California Endoscopic Retrograde Cholangiopancreatography Market
9.1. Introduction

10. Florida Endoscopic Retrograde Cholangiopancreatography Market
10.1. Introduction

11. Illinois Endoscopic Retrograde Cholangiopancreatography Market
11.1. Introduction

12. New York Endoscopic Retrograde Cholangiopancreatography Market
12.1. Introduction

13. Ohio Endoscopic Retrograde Cholangiopancreatography Market
13.1. Introduction

14. Pennsylvania Endoscopic Retrograde Cholangiopancreatography Market
14.1. Introduction

15. Texas Endoscopic Retrograde Cholangiopancreatography Market
15.1. Introduction

16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis, By Key Player
16.3. Market Share Analysis, By Key Player
16.4. Product Portfolio Analysis, By Key Player
16.5. Competitive Scenario
16.5.1. Merger & Acquisition
16.5.2. Agreement, Collaboration, & Partnership
16.5.3. New Product Launch & Enhancement
16.5.4. Investment & Funding
16.5.5. Award, Recognition, & Expansion

17. Company Usability Profiles
17.1. B. Braun Melsungen AG
17.2. Becton, Dickinson and Company
17.3. Boston Scientific Corporation
17.4. CONMED Corporation
17.5. Cook Group Incorporated
17.6. Fujifilm Holdings Corporation
17.7. Johnson & Johnson Services, Inc.
17.8. KARL STORZ SE & Co. KG
17.9. Machida Endoscope Co., Ltd
17.10. Medi-Globe GmbH
17.11. Medtronic PLC
17.12. Merit Medical Systems, Inc.
17.13. Olympus Corporation
17.14. Ottomed Endoscopy
17.15. PENTAX Medical
17.16. Richard Wolf GmbH
17.17. Smith & Nephew PLC
17.18. STERIS
17.19. Stryker Corporation

18. Appendix
18.1. Discussion Guide
18.2. License & Pricing

List of Figures
FIGURE 1. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, 2022 VS 2030
FIGURE 3. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 5. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 7. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET DYNAMICS
FIGURE 8. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 9. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 10. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT, 2030
FIGURE 12. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOSCOPES, 2018-2030 (USD MILLION)
FIGURE 13. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
FIGURE 14. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BALLOONS, 2018-2030 (USD MILLION)
FIGURE 15. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BASKETS, 2018-2030 (USD MILLION)
FIGURE 16. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY CANNULAS, 2018-2030 (USD MILLION)
FIGURE 17. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
FIGURE 18. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY FORCEPS, 2018-2030 (USD MILLION)
FIGURE 19. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY GUIDING WIRES, 2018-2030 (USD MILLION)
FIGURE 20. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY LITHOTRIPTER, 2018-2030 (USD MILLION)
FIGURE 21. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY SNARES, 2018-2030 (USD MILLION)
FIGURE 22. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY SPHINCTEROTOMES, 2018-2030 (USD MILLION)
FIGURE 23. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
FIGURE 24. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
FIGURE 25. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2030 (USD MILLION)
FIGURE 26. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2022 VS 2030 (%)
FIGURE 27. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 28. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET COMPETITIVE STRATEGIC WINDOW, BY PROCEDURE, 2030
FIGURE 29. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY DILATATION, 2018-2030 (USD MILLION)
FIGURE 30. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY SPHINCTEROTOMY, 2018-2030 (USD MILLION)
FIGURE 31. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY STENTING, 2018-2030 (USD MILLION)
FIGURE 32. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC DUCT DILATATION, 2018-2030 (USD MILLION)
FIGURE 33. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC DUCT STENTING, 2018-2030 (USD MILLION)
FIGURE 34. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC SPHINCTEROTOMY, 2018-2030 (USD MILLION)
FIGURE 35. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 36. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 37. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USER, 2030
FIGURE 38. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY AMBULATORY SURGERY CENTRES & CLINICS, 2018-2030 (USD MILLION)
FIGURE 39. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
FIGURE 40. CALIFORNIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 41. FLORIDA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 42. ILLINOIS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 43. NEW YORK ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 44. OHIO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 45. PENNSYLVANIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 46. TEXAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 47. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 48. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 49. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 5. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOSCOPES, 2018-2030 (USD MILLION)
TABLE 7. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOSCOPES, BY STATE, 2018-2030 (USD MILLION)
TABLE 8. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
TABLE 9. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, BY STATE, 2018-2030 (USD MILLION)
TABLE 10. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BALLOONS, 2018-2030 (USD MILLION)
TABLE 11. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BALLOONS, BY STATE, 2018-2030 (USD MILLION)
TABLE 12. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BASKETS, 2018-2030 (USD MILLION)
TABLE 13. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BASKETS, BY STATE, 2018-2030 (USD MILLION)
TABLE 14. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY CANNULAS, 2018-2030 (USD MILLION)
TABLE 15. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY CANNULAS, BY STATE, 2018-2030 (USD MILLION)
TABLE 16. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 17. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY CATHETERS, BY STATE, 2018-2030 (USD MILLION)
TABLE 18. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY FORCEPS, 2018-2030 (USD MILLION)
TABLE 19. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY FORCEPS, BY STATE, 2018-2030 (USD MILLION)
TABLE 20. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY GUIDING WIRES, 2018-2030 (USD MILLION)
TABLE 21. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY GUIDING WIRES, BY STATE, 2018-2030 (USD MILLION)
TABLE 22. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY LITHOTRIPTER, 2018-2030 (USD MILLION)
TABLE 23. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY LITHOTRIPTER, BY STATE, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY SNARES, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY SNARES, BY STATE, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY SPHINCTEROTOMES, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY SPHINCTEROTOMES, BY STATE, 2018-2030 (USD MILLION)
TABLE 28. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 29. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY STENTS, BY STATE, 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENERGY DEVICES, BY STATE, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY VISUALIZATION SYSTEMS, BY STATE, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY DILATATION, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY DILATATION, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY SPHINCTEROTOMY, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY SPHINCTEROTOMY, BY STATE, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY STENTING, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY STENTING, BY STATE, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC DUCT DILATATION, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC DUCT DILATATION, BY STATE, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC DUCT STENTING, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC DUCT STENTING, BY STATE, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC SPHINCTEROTOMY, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC SPHINCTEROTOMY, BY STATE, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY AMBULATORY SURGERY CENTRES & CLINICS, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY AMBULATORY SURGERY CENTRES & CLINICS, BY STATE, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY HOSPITALS, BY STATE, 2018-2030 (USD MILLION)
TABLE 52. CALIFORNIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 53. CALIFORNIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. CALIFORNIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 55. CALIFORNIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. FLORIDA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 57. FLORIDA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. FLORIDA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 59. FLORIDA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 60. ILLINOIS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 61. ILLINOIS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. ILLINOIS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 63. ILLINOIS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. NEW YORK ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 65. NEW YORK ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. NEW YORK ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 67. NEW YORK ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. OHIO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 69. OHIO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. OHIO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 71. OHIO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. PENNSYLVANIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 73. PENNSYLVANIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. PENNSYLVANIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 75. PENNSYLVANIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. TEXAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 77. TEXAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. TEXAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 79. TEXAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 81. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 82. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 83. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET RANKING, BY KEY PLAYER, 2022
TABLE 84. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SHARE, BY KEY PLAYER, 2022
TABLE 85. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 86. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET MERGER & ACQUISITION
TABLE 87. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 88. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 89. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET INVESTMENT & FUNDING
TABLE 90. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 91. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET: LICENSE & PRICING

Companies Mentioned

  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • CONMED Corporation
  • Cook Group Incorporated
  • Fujifilm Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • KARL STORZ SE & Co. KG
  • Machida Endoscope Co., Ltd
  • Medi-Globe GmbH
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Olympus Corporation
  • Ottomed Endoscopy
  • PENTAX Medical
  • Richard Wolf GmbH
  • Smith & Nephew PLC
  • STERIS
  • Stryker Corporation

Methodology

Loading
LOADING...